GOName,GOID,DiseaseName,DiseaseID,InferenceChemicalQty,InferenceChemicalNames,InferenceGeneQty,InferenceGeneSymbols
14-3-3 protein binding,GO:0071889,Alzheimer Disease,MESH:D000544,0,,1,ESR1
1-phosphatidylinositol binding,GO:0005545,Alzheimer Disease,MESH:D000544,0,,1,PICALM
"3',5'-cyclic-AMP phosphodiesterase activity",GO:0004115,Alzheimer Disease,MESH:D000544,1,Curcumin,0,
3-beta-hydroxy-delta5-steroid dehydrogenase activity,GO:0003854,Alzheimer Disease,MESH:D000544,2,Curcumin|Indomethacin,0,
3-hydroxybutyrate dehydrogenase activity,GO:0003858,Alzheimer Disease,MESH:D000544,1,Copper Sulfate,0,
3-phosphoinositide-dependent protein kinase activity,GO:0004676,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
3-phosphoinositide-dependent protein kinase binding,GO:0043423,Alzheimer Disease,MESH:D000544,0,,2,INSR|PTK2B
5'-nucleotidase activity,GO:0008253,Alzheimer Disease,MESH:D000544,1,Streptozocin,0,
ABC-type transporter activity,GO:0140359,Alzheimer Disease,MESH:D000544,0,,1,ABCA7
ABC-type transporter activity,GO:0140359,Alzheimer Disease 9,MESH:C563834,0,,1,ABCA7
ABC-type xenobiotic transporter activity,GO:0008559,Alzheimer Disease,MESH:D000544,1,Dronabinol,0,
acetylcholine binding,GO:0042166,Alzheimer Disease,MESH:D000544,0,,3,ACHE|CHRNA7|CHRNB2
acetylcholine-gated monoatomic cation-selective channel activity,GO:0022848,Alzheimer Disease,MESH:D000544,2,Dronabinol|Nicotine,2,CHRNA7|CHRNB2
acetylcholine receptor activator activity,GO:0030549,Alzheimer Disease,MESH:D000544,0,,1,APP
acetylcholine receptor activity,GO:0015464,Alzheimer Disease,MESH:D000544,0,,2,CHRNA7|CHRNB2
acetylcholine receptor binding,GO:0033130,Alzheimer Disease,MESH:D000544,0,,1,APP
acetylcholinesterase activity,GO:0003990,Alzheimer Disease,MESH:D000544,13,"Acetylcholine|Aluminum|Aluminum Chloride|Dronabinol|Ellagic Acid|Melatonin|Metals, Heavy|Particulate Matter|Plant Extracts|Reserpine|Rivastigmine|Scopolamine|Sodium Fluoride",3,ACE|ACHE|BCHE
acetyl-CoA carboxylase activity,GO:0003989,Alzheimer Disease,MESH:D000544,2,Glucose|Resveratrol,0,
acid phosphatase activity,GO:0003993,Alzheimer Disease,MESH:D000544,10,Cadmium|Copper Sulfate|cupric chloride|Curcumin|Fluorides|Folic Acid|Iron|Plant Extracts|Resveratrol|Streptozocin,0,
aconitate hydratase activity,GO:0003994,Alzheimer Disease,MESH:D000544,3,Hydrogen Peroxide|Streptozocin|Zinc,0,
actin binding,GO:0003779,Alzheimer Disease,MESH:D000544,0,,8,ABCA7|ACE|ARC|CD2AP|MAPT|NCK2|NOS3|SLC30A6
actin binding,GO:0003779,Alzheimer Disease 9,MESH:C563834,0,,1,ABCA7
actin filament binding,GO:0051015,Alzheimer Disease,MESH:D000544,0,,3,ABI3|BIN1|CD2AP
actin monomer binding,GO:0003785,Alzheimer Disease,MESH:D000544,0,,1,NOS3
active monoatomic ion transmembrane transporter activity,GO:0022853,Alzheimer Disease,MESH:D000544,1,Nicotine,0,
adenosine deaminase activity,GO:0004000,Alzheimer Disease,MESH:D000544,1,Zinc,0,
adenylate cyclase activator activity,GO:0010856,Alzheimer Disease,MESH:D000544,0,,1,CALM1
adenylate cyclase activity,GO:0004016,Alzheimer Disease,MESH:D000544,1,Dronabinol,0,
adenylate cyclase binding,GO:0008179,Alzheimer Disease,MESH:D000544,0,,2,CALM1|CHRNA7
adenylate kinase activity,GO:0004017,Alzheimer Disease,MESH:D000544,1,Berberine,0,
ADP binding,GO:0043531,Alzheimer Disease,MESH:D000544,0,,1,ATP5F1A
adrenergic receptor activity,GO:0004935,Alzheimer Disease,MESH:D000544,1,Nicotine,0,
alcohol dehydrogenase (NAD+) activity,GO:0004022,Alzheimer Disease,MESH:D000544,1,Curcumin,0,
aldehyde dehydrogenase [NAD(P)+] activity,GO:0004030,Alzheimer Disease,MESH:D000544,1,Plant Extracts,0,
alditol:NADP+ 1-oxidoreductase activity,GO:0004032,Alzheimer Disease,MESH:D000544,3,Berberine|Galactose|Streptozocin,0,
alkaline phosphatase activity,GO:0004035,Alzheimer Disease,MESH:D000544,24,"Aluminum Chloride|Amphotericin B|Cadmium|Cannabidiol|Colchicine|Curcumin|Ellagic Acid|Fluorides|Folic Acid|Glucose|Homocysteine|Hydrogen Peroxide|Nanotubes, Carbon|Niacin|Nicotine|Paroxetine|Plant Extracts|Raloxifene Hydrochloride|Resveratrol|Rosiglitazone|Sodium Fluoride|Streptozocin|Tadalafil|Zinc",0,
alpha-actinin binding,GO:0051393,Alzheimer Disease,MESH:D000544,0,,1,PPARG
alpha-amylase activity,GO:0004556,Alzheimer Disease,MESH:D000544,3,Berberine|Curcumin|Resveratrol,0,
alpha-glucosidase activity,GO:0090599,Alzheimer Disease,MESH:D000544,1,Berberine,0,
alpha-mannosidase activity,GO:0004559,Alzheimer Disease,MESH:D000544,1,Plant Preparations,0,
aminopeptidase activity,GO:0004177,Alzheimer Disease,MESH:D000544,5,Dichlorodiphenyl Dichloroethylene|Glucose|Hydrogen Peroxide|Streptozocin|Zinc,0,
AMP-activated protein kinase activity,GO:0004679,Alzheimer Disease,MESH:D000544,9,5-Methoxypsoralen|Berberine|Folic Acid|Glucose|Hydrogen Peroxide|Nicotine|Resveratrol|Streptozocin|Tadalafil,1,GSK3B
AMP deaminase activity,GO:0003876,Alzheimer Disease,MESH:D000544,1,cupric chloride,0,
amylase activity,GO:0016160,Alzheimer Disease,MESH:D000544,3,"Cadmium|Heparin, Low-Molecular-Weight|Streptozocin",0,
amylin binding,GO:0097645,Alzheimer Disease,MESH:D000544,0,,1,APP
amyloid-beta binding,GO:0001540,Alzheimer Disease,MESH:D000544,0,,13,ACHE|APOE|BACE1|BCHE|CHRNA7|CLU|CST3|IDE|INSR|PGRMC1|PICALM|PRNP|TREM2
amyloid-beta binding,GO:0001540,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
amyloid-beta binding,GO:0001540,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
amyloid-beta binding,GO:0001540,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
"anandamide 11,12 epoxidase activity",GO:0062188,Alzheimer Disease,MESH:D000544,0,,1,CYP2D6
"anandamide 14,15 epoxidase activity",GO:0062189,Alzheimer Disease,MESH:D000544,0,,1,CYP2D6
"anandamide 8,9 epoxidase activity",GO:0062187,Alzheimer Disease,MESH:D000544,0,,1,CYP2D6
angiostatin binding,GO:0043532,Alzheimer Disease,MESH:D000544,0,,1,ATP5F1A
antioxidant activity,GO:0016209,Alzheimer Disease,MESH:D000544,5,Cannabidiol|Colchicine|Curcumin|Melatonin|Particulate Matter,2,APOE|SOD2
antioxidant activity,GO:0016209,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
antioxidant activity,GO:0016209,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
antioxidant activity,GO:0016209,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
antiporter activity,GO:0015297,Alzheimer Disease,MESH:D000544,0,,1,SLC30A4
apolipoprotein A-I binding,GO:0034186,Alzheimer Disease,MESH:D000544,0,,1,TREM2
apolipoprotein A-I receptor activity,GO:0034188,Alzheimer Disease,MESH:D000544,0,,1,ABCA7
apolipoprotein A-I receptor activity,GO:0034188,Alzheimer Disease 9,MESH:C563834,0,,1,ABCA7
apolipoprotein binding,GO:0034185,Alzheimer Disease,MESH:D000544,0,,3,APP|MAPT|TREM2
arachidonic acid binding,GO:0050544,Alzheimer Disease,MESH:D000544,0,,1,PPARG
arachidonic acid omega-hydroxylase activity,GO:0052869,Alzheimer Disease,MESH:D000544,0,,1,HMOX1
arginase activity,GO:0004053,Alzheimer Disease,MESH:D000544,3,Haloperidol|Streptozocin|Zinc,0,
arginine binding,GO:0034618,Alzheimer Disease,MESH:D000544,0,,1,NOS3
arylesterase activity,GO:0004064,Alzheimer Disease,MESH:D000544,1,Copper Sulfate,0,
"aspartic endopeptidase activity, intramembrane cleaving",GO:0042500,Alzheimer Disease,MESH:D000544,0,,3,NCSTN|PSEN1|PSEN2
"aspartic endopeptidase activity, intramembrane cleaving",GO:0042500,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,PSEN1
"aspartic endopeptidase activity, intramembrane cleaving",GO:0042500,Alzheimer disease type 4,MESH:C536596,0,,1,PSEN2
aspartic-type endopeptidase activity,GO:0004190,Alzheimer Disease,MESH:D000544,0,,5,ARC|BACE1|CASP3|PSEN1|PSEN2
aspartic-type endopeptidase activity,GO:0004190,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,PSEN1
aspartic-type endopeptidase activity,GO:0004190,Alzheimer disease type 4,MESH:C536596,0,,1,PSEN2
aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,GO:1902944,Alzheimer Disease,MESH:D000544,1,Nicotine,0,
aspartic-type endopeptidase inhibitor activity,GO:0019828,Alzheimer Disease,MESH:D000544,0,,2,BIN1|PRNP
ATP-activated inward rectifier potassium channel activity,GO:0015272,Alzheimer Disease,MESH:D000544,1,Zinc,0,
ATPase binding,GO:0051117,Alzheimer Disease,MESH:D000544,0,,4,CHRNA7|ESR1|NCSTN|PSEN1
ATPase binding,GO:0051117,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,PSEN1
ATPase-coupled monoatomic cation transmembrane transporter activity,GO:0019829,Alzheimer Disease,MESH:D000544,0,,1,ATP7
ATP binding,GO:0005524,Alzheimer Disease,MESH:D000544,0,,11,ABCA7|ATP5F1A|ATP7|CTR1B|EPHA1|GSK3B|IDE|IGF1R|INSR|NECTIN2|PTK2B
ATP binding,GO:0005524,Alzheimer Disease 9,MESH:C563834,0,,1,ABCA7
ATP-dependent activity,GO:0140657,Alzheimer Disease,MESH:D000544,5,Galactose|Haloperidol|Iron|Sodium Fluoride|Streptozocin,0,
ATP-dependent protein binding,GO:0043008,Alzheimer Disease,MESH:D000544,0,,1,PRNP
ATP hydrolysis activity,GO:0016887,Alzheimer Disease,MESH:D000544,8,Cadmium|Deferoxamine|Glucose|Hydrogen Peroxide|Particulate Matter|Plant Extracts|Resveratrol|Streptozocin,4,ABCA7|ATP5F1A|ATP7|IDE
ATP hydrolysis activity,GO:0016887,Alzheimer Disease 9,MESH:C563834,0,,1,ABCA7
A-type (transient outward) potassium channel activity,GO:0005250,Alzheimer Disease,MESH:D000544,1,Serotonin,0,
BAT3 complex binding,GO:1904288,Alzheimer Disease,MESH:D000544,0,,1,AMFR
beta-2-microglobulin binding,GO:0030881,Alzheimer Disease,MESH:D000544,0,,1,HFE
beta-aspartyl-peptidase activity,GO:0008798,Alzheimer Disease,MESH:D000544,0,,1,BACE1
beta-catenin binding,GO:0008013,Alzheimer Disease,MESH:D000544,0,,6,CD2AP|ESR1|GSK3B|NOS3|PSEN1|TREM2
beta-catenin binding,GO:0008013,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,PSEN1
beta-endorphin binding,GO:0031626,Alzheimer Disease,MESH:D000544,0,,1,IDE
beta-galactosidase activity,GO:0004565,Alzheimer Disease,MESH:D000544,7,Air Pollutants|Aluminum Chloride|Cannabidiol|Dronabinol|Galactose|Particulate Matter|Resveratrol,0,
BH3 domain binding,GO:0051434,Alzheimer Disease,MESH:D000544,0,,2,BAX|BCL2
BH domain binding,GO:0051400,Alzheimer Disease,MESH:D000544,0,,2,BAX|BCL2
boss receptor activity,GO:0008288,Alzheimer Disease,MESH:D000544,0,,3,EPHA1|IGF1R|INSR
bradykinin receptor binding,GO:0031711,Alzheimer Disease,MESH:D000544,0,,1,ACE
brain-derived neurotrophic factor binding,GO:0048403,Alzheimer Disease,MESH:D000544,0,,1,A2M
brain-derived neurotrophic factor receptor activity,GO:0060175,Alzheimer Disease,MESH:D000544,0,,3,EPHA1|IGF1R|INSR
cadherin binding,GO:0045296,Alzheimer Disease,MESH:D000544,0,,4,CD2AP|NOS3|PCDH11X|PSEN1
cadherin binding,GO:0045296,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,PSEN1
cadmium ion binding,GO:0046870,Alzheimer Disease,MESH:D000544,0,,1,NOS3
calcium channel activity,GO:0005262,Alzheimer Disease,MESH:D000544,4,Cannabidiol|Dronabinol|Raloxifene Hydrochloride|Zinc,2,CHRNA7|PSEN1
calcium channel activity,GO:0005262,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,PSEN1
calcium channel inhibitor activity,GO:0019855,Alzheimer Disease,MESH:D000544,0,,1,CALM1
calcium channel regulator activity,GO:0005246,Alzheimer Disease,MESH:D000544,0,,2,CALM1|NPY
calcium-dependent ATPase activity,GO:0030899,Alzheimer Disease,MESH:D000544,2,Berberine|Cadmium,0,
calcium-dependent cysteine-type endopeptidase activity,GO:0004198,Alzheimer Disease,MESH:D000544,1,Glucose,0,
calcium-dependent protein binding,GO:0048306,Alzheimer Disease,MESH:D000544,0,,2,A2M|CALM1
calcium ion binding,GO:0005509,Alzheimer Disease,MESH:D000544,0,,9,ARC|BCHE|CALM1|F2|NCSTN|PCDH11X|PLAU|TPP1|VSNL1
calmodulin binding,GO:0005516,Alzheimer Disease,MESH:D000544,0,,3,ACE|ESR1|NOS3
calmodulin-dependent protein kinase activity,GO:0004683,Alzheimer Disease,MESH:D000544,0,,1,PTK2B
cAMP-dependent protein kinase activity,GO:0004691,Alzheimer Disease,MESH:D000544,1,Glucose,0,
carbohydrate binding,GO:0030246,Alzheimer Disease,MESH:D000544,0,,1,CD33
carbonate dehydratase activity,GO:0004089,Alzheimer Disease,MESH:D000544,2,Copper|Streptozocin,0,
carboxylic ester hydrolase activity,GO:0052689,Alzheimer Disease,MESH:D000544,0,,2,ACHE|BCHE
carboxypeptidase activity,GO:0004180,Alzheimer Disease,MESH:D000544,0,,1,ACE
cargo receptor activity,GO:0038024,Alzheimer Disease,MESH:D000544,0,,1,INSR
carnitine O-palmitoyltransferase activity,GO:0004095,Alzheimer Disease,MESH:D000544,3,Copper|Copper Sulfate|Resveratrol,0,
catalase activity,GO:0004096,Alzheimer Disease,MESH:D000544,1,Copper Sulfate,0,
catalytic activity,GO:0003824,Alzheimer Disease,MESH:D000544,0,,3,BCHE|INPP5D|WWOX
CD40 receptor binding,GO:0005174,Alzheimer Disease,MESH:D000544,0,,1,TNF
cell adhesion molecule binding,GO:0050839,Alzheimer Disease,MESH:D000544,0,,1,NECTIN2
channel activity,GO:0015267,Alzheimer Disease,MESH:D000544,4,Cadmium|Copper|Glucose|Zinc,2,BAX|BCL2
channel inhibitor activity,GO:0016248,Alzheimer Disease,MESH:D000544,0,,1,BCL2
chaperone binding,GO:0051087,Alzheimer Disease,MESH:D000544,0,,7,AMFR|APP|BAX|BIN1|CLU|MAPT|PRNP
chemoattractant activity,GO:0042056,Alzheimer Disease,MESH:D000544,0,,2,APP|VEGFA
chloride channel regulator activity,GO:0017081,Alzheimer Disease,MESH:D000544,0,,1,CHRNA7
chloride ion binding,GO:0031404,Alzheimer Disease,MESH:D000544,0,,1,ACE
cholesterol 24-hydroxylase activity,GO:0033781,Alzheimer Disease,MESH:D000544,0,,1,CYP46A1
cholesterol transfer activity,GO:0120020,Alzheimer Disease,MESH:D000544,0,,1,APOE
cholesterol transfer activity,GO:0120020,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
cholesterol transfer activity,GO:0120020,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
cholesterol transfer activity,GO:0120020,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
choline binding,GO:0033265,Alzheimer Disease,MESH:D000544,0,,2,ACHE|BCHE
cholinesterase activity,GO:0004104,Alzheimer Disease,MESH:D000544,3,Ginkgo biloba extract|Physostigmine|Tacrine,3,ACE|ACHE|BCHE
cholinesterase activity,GO:0004104,Alzheimer disease type 2,MESH:C536595,1,Manganese,0,
chromatin binding,GO:0003682,Alzheimer Disease,MESH:D000544,0,,5,APP|ESR1|MPO|PPARG|TFAM
citrate synthase activity,GO:0036440,Alzheimer Disease,MESH:D000544,3,Galactose|Glucose|Streptozocin,0,
clathrin binding,GO:0030276,Alzheimer Disease,MESH:D000544,0,,3,BIN1|CD2AP|PICALM
clathrin heavy chain binding,GO:0032050,Alzheimer Disease,MESH:D000544,0,,1,PICALM
collagen binding,GO:0005518,Alzheimer Disease,MESH:D000544,0,,1,ACHE
collagen binding involved in cell-matrix adhesion,GO:0098639,Alzheimer Disease,MESH:D000544,1,Resveratrol,0,
complement component C3b binding,GO:0001851,Alzheimer Disease,MESH:D000544,0,,1,CR1
complement component C3b receptor activity,GO:0004877,Alzheimer Disease,MESH:D000544,0,,1,CR1
complement component C4b binding,GO:0001855,Alzheimer Disease,MESH:D000544,0,,1,CR1
complement component C4b receptor activity,GO:0001861,Alzheimer Disease,MESH:D000544,0,,1,CR1
copper ion binding,GO:0005507,Alzheimer Disease,MESH:D000544,0,,2,ATP7|PRNP
copper ion transmembrane transporter activity,GO:0005375,Alzheimer Disease,MESH:D000544,0,,3,ATP7|CTR1B|CTR1C
coreceptor activity,GO:0015026,Alzheimer Disease,MESH:D000544,0,,1,NECTIN2
co-receptor binding,GO:0039706,Alzheimer Disease,MESH:D000544,0,,1,HFE
corticotropin-releasing hormone activity,GO:0017045,Alzheimer Disease,MESH:D000544,0,,1,CRH
corticotropin-releasing hormone receptor 1 binding,GO:0051430,Alzheimer Disease,MESH:D000544,0,,1,CRH
corticotropin-releasing hormone receptor 2 binding,GO:0051431,Alzheimer Disease,MESH:D000544,0,,1,CRH
creatine kinase activity,GO:0004111,Alzheimer Disease,MESH:D000544,6,"Cadmium|Cholesterol, Dietary|Copper Sulfate|Ellagic Acid|Resveratrol|Streptozocin",0,
cupric ion binding,GO:1903135,Alzheimer Disease,MESH:D000544,0,,1,PRNP
cuprous ion binding,GO:1903136,Alzheimer Disease,MESH:D000544,0,,1,PRNP
cyclin-dependent protein serine/threonine kinase inhibitor activity,GO:0004861,Alzheimer Disease,MESH:D000544,0,,1,CASP3
cysteine-type endopeptidase activity,GO:0004197,Alzheimer Disease,MESH:D000544,10,"Acrolein|Cadmium|Cannabidiol|Celecoxib|Dronabinol|Glucose|Hydrogen Peroxide|Nanotubes, Carbon|Particulate Matter|Raloxifene Hydrochloride",1,CASP3
cysteine-type endopeptidase activity involved in apoptotic process,GO:0097153,Alzheimer Disease,MESH:D000544,4,Cannabidiol|Folic Acid|Glucose|Homocysteine,0,
cysteine-type endopeptidase inhibitor activity,GO:0004869,Alzheimer Disease,MESH:D000544,0,,1,CST3
cysteine-type peptidase activity,GO:0008234,Alzheimer Disease,MESH:D000544,1,Dichlorodiphenyl Dichloroethylene,1,CASP3
"cytochrome-b5 reductase activity, acting on NADH",GO:0090524,Alzheimer Disease,MESH:D000544,1,cupric chloride,0,
cytochrome-c oxidase activity,GO:0004129,Alzheimer Disease,MESH:D000544,22,2-butenal|Acrolein|Air Pollutants|Berberine|Cadmium|Cannabidiol|Celecoxib|Copper|Copper Sulfate|Curcumin|Deferoxamine|Dronabinol|Ellagic Acid|Glucose|Hydrogen Peroxide|Iron|Nitrites|Ozone|Particulate Matter|Resveratrol|Streptozocin|Zinc,0,
cytokine activity,GO:0005125,Alzheimer Disease,MESH:D000544,0,,4,IL1B|LEP|TNF|VEGFA
cytoskeletal anchor activity,GO:0008093,Alzheimer Disease,MESH:D000544,0,,1,NCK2
D-alanine:2-oxoglutarate aminotransferase activity,GO:0047810,Alzheimer Disease,MESH:D000544,1,Curcumin,0,
death receptor agonist activity,GO:0038177,Alzheimer Disease,MESH:D000544,0,,1,TNF
death receptor binding,GO:0005123,Alzheimer Disease,MESH:D000544,0,,1,CASP3
delta24(24-1) sterol reductase activity,GO:0000246,Alzheimer Disease,MESH:D000544,0,,1,DHCR24
delta24-sterol reductase activity,GO:0050614,Alzheimer Disease,MESH:D000544,0,,1,DHCR24
D-glucose transmembrane transporter activity,GO:0055056,Alzheimer Disease,MESH:D000544,0,,1,SLC2A4
D-glutamyltransferase activity,GO:0047823,Alzheimer Disease,MESH:D000544,6,Air Pollutants|Folic Acid|Hydrogen Peroxide|Particulate Matter|Streptozocin|Zinc,0,
dimethylargininase activity,GO:0016403,Alzheimer Disease,MESH:D000544,2,Folic Acid|Homocysteine,0,
D-lactate dehydrogenase activity,GO:0008720,Alzheimer Disease,MESH:D000544,1,cupric chloride,0,
DNA binding,GO:0003677,Alzheimer Disease,MESH:D000544,0,,9,ABCA7|APP|ESR1|INPP5D|LEP|MAPT|PPARG|SOD2|TFAM
DNA binding,GO:0003677,Alzheimer Disease 9,MESH:C563834,0,,1,ABCA7
"DNA binding, bending",GO:0008301,Alzheimer Disease,MESH:D000544,0,,1,TFAM
DNA binding domain binding,GO:0050692,Alzheimer Disease,MESH:D000544,0,,1,PPARG
"DNA-binding transcription activator activity, RNA polymerase II-specific",GO:0001228,Alzheimer Disease,MESH:D000544,0,,2,ESR1|PPARG
DNA-binding transcription factor activity,GO:0003700,Alzheimer Disease,MESH:D000544,2,Cadmium|Ozone,2,ESR1|PPARG
"DNA-binding transcription factor activity, RNA polymerase II-specific",GO:0000981,Alzheimer Disease,MESH:D000544,0,,3,ESR1|F2|PPARG
DNA-binding transcription factor binding,GO:0140297,Alzheimer Disease,MESH:D000544,0,,3,BCL2|BIN1|PPARG
"DNA-binding transcription repressor activity, RNA polymerase II-specific",GO:0001227,Alzheimer Disease,MESH:D000544,0,,2,ENO1|PPARG
DNA-dependent protein kinase activity,GO:0004677,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
DNA-directed DNA polymerase activity,GO:0003887,Alzheimer Disease,MESH:D000544,1,Hydrogen Peroxide,0,
DNA-methyltransferase activity,GO:0009008,Alzheimer Disease,MESH:D000544,4,Curcumin|Folic Acid|Hydrogen Peroxide|Plant Extracts,0,
double-stranded DNA binding,GO:0003690,Alzheimer Disease,MESH:D000544,0,,2,MAPT|PPARG
dynactin binding,GO:0034452,Alzheimer Disease,MESH:D000544,0,,2,GSK3B|MAPT
dynein complex binding,GO:0070840,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
E-box binding,GO:0070888,Alzheimer Disease,MESH:D000544,0,,1,PPARG
electron transfer activity,GO:0009055,Alzheimer Disease,MESH:D000544,1,2-butenal,2,ADAM10|MAOB
electron transfer activity,GO:0009055,ALZHEIMER DISEASE 18,OMIM:615590,0,,1,ADAM10
endopeptidase activator activity,GO:0061133,Alzheimer Disease,MESH:D000544,0,,2,APH1B|NCSTN
endopeptidase activity,GO:0004175,Alzheimer Disease,MESH:D000544,2,Particulate Matter|Streptozocin,10,ACE|ADAM10|BACE1|CASP3|F2|IDE|NCSTN|PSEN1|PSEN2|TPP1
endopeptidase activity,GO:0004175,ALZHEIMER DISEASE 18,OMIM:615590,0,,1,ADAM10
endopeptidase activity,GO:0004175,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,PSEN1
endopeptidase activity,GO:0004175,Alzheimer disease type 4,MESH:C536596,0,,1,PSEN2
endopeptidase inhibitor activity,GO:0004866,Alzheimer Disease,MESH:D000544,0,,2,A2M|CST3
enzyme binding,GO:0019899,Alzheimer Disease,MESH:D000544,0,,17,A2M|APOE|APP|BACE1|BCHE|DHCR24|ENO1|ESR1|HMOX1|IGF2R|MAPT|PPARG|PTK2B|SOD2|TF|TSPAN14|WWOX
enzyme binding,GO:0019899,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
enzyme binding,GO:0019899,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
enzyme binding,GO:0019899,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
enzyme regulator activity,GO:0030234,Alzheimer Disease,MESH:D000544,0,,1,CALM1
ephrin receptor activity,GO:0005003,Alzheimer Disease,MESH:D000544,0,,1,EPHA1
ephrin receptor binding,GO:0046875,Alzheimer Disease,MESH:D000544,0,,1,APP
epidermal growth factor receptor activity,GO:0005006,Alzheimer Disease,MESH:D000544,0,,3,EPHA1|IGF1R|INSR
estradiol 17-beta-dehydrogenase activity,GO:0004303,Alzheimer Disease,MESH:D000544,2,Curcumin|Indomethacin,0,
estradiol binding,GO:1903924,Alzheimer Disease,MESH:D000544,0,,1,ESR1
estrogen binding,GO:0099130,Alzheimer Disease,MESH:D000544,0,,1,ESR1
estrogen response element binding,GO:0034056,Alzheimer Disease,MESH:D000544,0,,1,ESR1
eukaryotic translation initiation factor 2alpha kinase activity,GO:0004694,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
exopeptidase activity,GO:0008238,Alzheimer Disease,MESH:D000544,0,,1,ACE
extracellular ligand-gated monoatomic ion channel activity,GO:0005230,Alzheimer Disease,MESH:D000544,0,,2,CHRNA7|CHRNB2
extracellularly glutamate-gated chloride channel activity,GO:0008068,Alzheimer Disease,MESH:D000544,1,Ibotenic Acid,0,
extracellular matrix binding,GO:0050840,Alzheimer Disease,MESH:D000544,0,,1,VEGFA
extracellular matrix structural constituent,GO:0005201,Alzheimer Disease,MESH:D000544,0,,1,RELN
FAD binding,GO:0071949,Alzheimer Disease,MESH:D000544,0,,2,DHCR24|MTHFR
fatty acid binding,GO:0005504,Alzheimer Disease,MESH:D000544,0,,1,APOC1
ferric iron binding,GO:0008199,Alzheimer Disease,MESH:D000544,0,,1,TF
ferrous iron binding,GO:0008198,Alzheimer Disease,MESH:D000544,0,,1,TF
fibroblast growth factor receptor activity,GO:0005007,Alzheimer Disease,MESH:D000544,0,,3,EPHA1|IGF1R|INSR
fibronectin binding,GO:0001968,Alzheimer Disease,MESH:D000544,0,,2,EPHA1|VEGFA
flavin adenine dinucleotide binding,GO:0050660,Alzheimer Disease,MESH:D000544,0,,4,DHCR24|MAOB|MTHFR|NOS3
floppase activity,GO:0140328,Alzheimer Disease,MESH:D000544,0,,1,ABCA7
floppase activity,GO:0140328,Alzheimer Disease 9,MESH:C563834,0,,1,ABCA7
FMN binding,GO:0010181,Alzheimer Disease,MESH:D000544,0,,1,NOS3
frizzled binding,GO:0005109,Alzheimer Disease,MESH:D000544,0,,1,APP
"fructose 1,6-bisphosphate 1-phosphatase activity",GO:0042132,Alzheimer Disease,MESH:D000544,1,Streptozocin,0,
gap junction channel activity,GO:0005243,Alzheimer Disease,MESH:D000544,3,Air Pollutants|Particulate Matter|Resveratrol,0,
Gi/o-coupled serotonin receptor activity,GO:0001586,Alzheimer Disease,MESH:D000544,1,Dronabinol,0,
glucokinase activity,GO:0004340,Alzheimer Disease,MESH:D000544,3,Plant Extracts|Streptozocin|Tadalafil,0,
glucose-6-phosphatase activity,GO:0004346,Alzheimer Disease,MESH:D000544,3,Plant Extracts|Streptozocin|Tadalafil,0,
glucose-6-phosphate dehydrogenase activity,GO:0004345,Alzheimer Disease,MESH:D000544,2,Plant Extracts|Streptozocin,0,
glucose uniporter activity,GO:0015304,Alzheimer Disease,MESH:D000544,0,,1,SLC2A4
glucuronosyltransferase activity,GO:0015020,Alzheimer Disease,MESH:D000544,1,Plant Preparations,0,
glutamate-cysteine ligase activity,GO:0004357,Alzheimer Disease,MESH:D000544,1,Cadmium,0,
glutamate dehydrogenase (NAD+) activity,GO:0004352,Alzheimer Disease,MESH:D000544,1,Melatonin,0,
glutamate receptor binding,GO:0035254,Alzheimer Disease,MESH:D000544,0,,1,PTK2B
glutathione binding,GO:0043295,Alzheimer Disease,MESH:D000544,2,Copper|Copper Sulfate,0,
glutathione binding,GO:0043295,Alzheimer disease type 2,MESH:C536595,1,Manganese,0,
glutathione hydrolase activity,GO:0036374,Alzheimer Disease,MESH:D000544,1,Copper Sulfate,0,
glutathione peroxidase activity,GO:0004602,Alzheimer Disease,MESH:D000544,44,"5-Methoxypsoralen|Acrolein|Air Pollutants|Aluminum|Aluminum Chloride|Apigenin|Berberine|Cadmium|Cannabidiol|Cholesterol, Dietary|Copper|Copper Sulfate|Curcumin|Deferoxamine|Dichlorodiphenyl Dichloroethylene|Ellagic Acid|Fluorides|Folic Acid|Galactose|Ginkgo biloba extract|Glucose|Homocysteine|Hydrogen Peroxide|Indomethacin|Iron|Kainic Acid|Lithium|Melatonin|Mifepristone|Nanotubes, Carbon|Nicotine|Ozone|Particulate Matter|Plant Extracts|Plant Preparations|Resveratrol|Rosiglitazone|Scopolamine|Serotonin|Sodium Fluoride|Streptozocin|Tacrine|Trichlorfon|Zinc",0,
glutathione peroxidase activity,GO:0004602,Alzheimer disease type 2,MESH:C536595,1,Manganese,0,
glutathione transferase activity,GO:0004364,Alzheimer Disease,MESH:D000544,26,"Apigenin|Cadmium|Copper|Copper Sulfate|Curcumin|Dichlorodiphenyl Dichloroethylene|Ellagic Acid|Fluorides|Folic Acid|Galactose|Glucose|Iron|Melatonin|Metals, Heavy|Nanotubes, Carbon|Nicotine|Ozone|Particulate Matter|Plant Extracts|Plant Preparations|Resveratrol|Sodium Fluoride|Streptozocin|tideglusib|Vitamin B 12|Zinc",0,
glutathione transferase activity,GO:0004364,Alzheimer disease type 2,MESH:C536595,1,Manganese,0,
glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,GO:0004365,Alzheimer Disease,MESH:D000544,1,Glucose,1,GAPDHS
glycerol-3-phosphate O-acyltransferase activity,GO:0004366,Alzheimer Disease,MESH:D000544,1,Resveratrol,0,
glycogen phosphorylase activity,GO:0008184,Alzheimer Disease,MESH:D000544,3,Plant Extracts|Streptozocin|Tadalafil,0,
glycogen (starch) synthase activity,GO:0004373,Alzheimer Disease,MESH:D000544,2,Plant Extracts|Streptozocin,0,
glycosaminoglycan binding,GO:0005539,Alzheimer Disease,MESH:D000544,0,,1,PRNP
GPI-linked ephrin receptor activity,GO:0005004,Alzheimer Disease,MESH:D000544,0,,3,EPHA1|IGF1R|INSR
G-protein alpha-subunit binding,GO:0001965,Alzheimer Disease,MESH:D000544,0,,2,IGF1R|IGF2R
G protein-coupled estrogen receptor activity,GO:0038054,Alzheimer Disease,MESH:D000544,0,,1,ESR1
G protein-coupled receptor activity,GO:0004930,Alzheimer Disease,MESH:D000544,0,,2,CR1|NPY
G protein-coupled receptor binding,GO:0001664,Alzheimer Disease,MESH:D000544,0,,3,APP|NPY|PYY
growth factor activity,GO:0008083,Alzheimer Disease,MESH:D000544,0,,5,BDNF|F2|IGF1|IGF2|VEGFA
growth factor binding,GO:0019838,Alzheimer Disease,MESH:D000544,0,,2,A2M|VEGFA
growth factor receptor binding,GO:0070851,Alzheimer Disease,MESH:D000544,0,,3,APP|NCSTN|PSEN1
growth factor receptor binding,GO:0070851,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,PSEN1
GTPase binding,GO:0051020,Alzheimer Disease,MESH:D000544,0,,2,BIN1|ENO1
GTP binding,GO:0005525,Alzheimer Disease,MESH:D000544,0,,3,INSR|IQCK|TF
guanyl-nucleotide exchange factor activity,GO:0005085,Alzheimer Disease,MESH:D000544,0,,1,INSR
H3K27me3 modified histone binding,GO:0061628,Alzheimer Disease,MESH:D000544,2,Dichlorodiphenyl Dichloroethylene|Particulate Matter,0,
H3K9me3 modified histone binding,GO:0062072,Alzheimer Disease,MESH:D000544,1,Dronabinol,0,
heat shock protein binding,GO:0031072,Alzheimer Disease,MESH:D000544,0,,4,BAX|ENO1|MAPT|TFAM
heme binding,GO:0020037,Alzheimer Disease,MESH:D000544,0,,7,ADAM10|CYP2D6|CYP46A1|HMOX1|MPO|NOS3|PGRMC1
heme binding,GO:0020037,ALZHEIMER DISEASE 18,OMIM:615590,0,,1,ADAM10
heme oxygenase (decyclizing) activity,GO:0004392,Alzheimer Disease,MESH:D000544,2,Cannabidiol|Dronabinol,1,HMOX1
heparan sulfate binding,GO:1904399,Alzheimer Disease,MESH:D000544,0,,1,APP
heparan sulfate proteoglycan binding,GO:0043395,Alzheimer Disease,MESH:D000544,0,,2,APOE|APP
heparan sulfate proteoglycan binding,GO:0043395,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
heparan sulfate proteoglycan binding,GO:0043395,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
heparan sulfate proteoglycan binding,GO:0043395,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
heparin binding,GO:0008201,Alzheimer Disease,MESH:D000544,0,,6,ADAMTS1|APOE|APP|F2|MPO|VEGFA
heparin binding,GO:0008201,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
heparin binding,GO:0008201,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
heparin binding,GO:0008201,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
hepatocyte growth factor receptor activity,GO:0005008,Alzheimer Disease,MESH:D000544,0,,3,EPHA1|IGF1R|INSR
heterocyclic compound binding,GO:1901363,Alzheimer Disease,MESH:D000544,0,,2,ACE|CHRNB2
hexokinase activity,GO:0004396,Alzheimer Disease,MESH:D000544,4,Air Pollutants|Indomethacin|Particulate Matter|Streptozocin,0,
hexose transmembrane transporter activity,GO:0015149,Alzheimer Disease,MESH:D000544,0,,1,SLC2A4
high-density lipoprotein particle binding,GO:0008035,Alzheimer Disease,MESH:D000544,0,,1,TREM2
high voltage-gated calcium channel activity,GO:0008331,Alzheimer Disease,MESH:D000544,1,Particulate Matter,0,
histone acetyltransferase activity,GO:0004402,Alzheimer Disease,MESH:D000544,1,Curcumin,0,
histone deacetylase activity,GO:0004407,Alzheimer Disease,MESH:D000544,4,Apigenin|Curcumin|Plant Extracts|Streptozocin,0,
histone-dependent DNA binding,GO:0099077,Alzheimer Disease,MESH:D000544,0,,1,MAPT
histone H2AS121 kinase activity,GO:0072371,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
histone H2AS139 kinase activity,GO:0035979,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
histone H2AS1 kinase activity,GO:0044024,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
histone H2AT120 kinase activity,GO:1990244,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
histone H2BS14 kinase activity,GO:0044025,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
histone H2BS36 kinase activity,GO:0140823,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
histone H3K9 demethylase activity,GO:0032454,Alzheimer Disease,MESH:D000544,2,Melatonin|Particulate Matter,0,
histone H3S10 kinase activity,GO:0035175,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
histone H3S28 kinase activity,GO:0044022,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
histone H3S57 kinase activity,GO:0140855,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
histone H3T11 kinase activity,GO:0035402,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
histone H3T3 kinase activity,GO:0072354,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
histone H3T45 kinase activity,GO:0140857,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
histone H3T6 kinase activity,GO:0035403,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
histone H4S1 kinase activity,GO:0044023,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
hormone activity,GO:0005179,Alzheimer Disease,MESH:D000544,0,,7,CRH|IGF1|IGF2|INS|LEP|NPY|PYY
hormone binding,GO:0042562,Alzheimer Disease,MESH:D000544,0,,1,ESR1
Hsp70 protein binding,GO:0030544,Alzheimer Disease,MESH:D000544,0,,1,BAX
Hsp90 protein binding,GO:0051879,Alzheimer Disease,MESH:D000544,0,,2,MAPT|NOS3
hyaluronic acid binding,GO:0005540,Alzheimer Disease,MESH:D000544,0,,1,F2
hydrolase activity,GO:0016787,Alzheimer Disease,MESH:D000544,0,,11,ACE|ACHE|ADAMTS1|BACE1|F2|IDE|PLCG2|PSEN1|PSEN2|RELN|TPP1
hydrolase activity,GO:0016787,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,PSEN1
hydrolase activity,GO:0016787,Alzheimer disease type 4,MESH:C536596,0,,1,PSEN2
"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds",GO:0016810,Alzheimer Disease,MESH:D000544,0,,1,DPYSL2
"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides",GO:0016812,Alzheimer Disease,MESH:D000544,0,,1,DPYSL2
"hydrolase activity, acting on ester bonds",GO:0016788,Alzheimer Disease,MESH:D000544,0,,1,BCHE
hydroxyapatite binding,GO:0046848,Alzheimer Disease,MESH:D000544,0,,1,APOE
hydroxyapatite binding,GO:0046848,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
hydroxyapatite binding,GO:0046848,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
hydroxyapatite binding,GO:0046848,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
identical protein binding,GO:0042802,Alzheimer Disease,MESH:D000544,0,,32,A2M|ABI3|ACHE|AMFR|APOE|APP|BAX|BCHE|BCL2|BIN1|CCDC6|CD2AP|CST3|DPYSL2|ENO1|ESR1|HMOX1|IDE|IGF1R|IGF2R|INS|INSR|MAOB|MAPT|NECTIN2|PICALM|PPARG|PRNP|SOD2|TNF|VEGFA|WWOX
identical protein binding,GO:0042802,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
identical protein binding,GO:0042802,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
identical protein binding,GO:0042802,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
IgA receptor activity,GO:0019766,Alzheimer Disease,MESH:D000544,1,Dichlorodiphenyl Dichloroethylene,0,
IgG receptor activity,GO:0019770,Alzheimer Disease,MESH:D000544,1,Dichlorodiphenyl Dichloroethylene,0,
IkappaB kinase activity,GO:0008384,Alzheimer Disease,MESH:D000544,1,Resveratrol,0,
"indoleamine 2,3-dioxygenase activity",GO:0033754,Alzheimer Disease,MESH:D000544,1,Cadmium,0,
"inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity",GO:0052659,Alzheimer Disease,MESH:D000544,0,,1,INPP5D
"inositol-4,5-bisphosphate 5-phosphatase activity",GO:0030487,Alzheimer Disease,MESH:D000544,0,,1,INPP5D
inositol-polyphosphate 5-phosphatase activity,GO:0004445,Alzheimer Disease,MESH:D000544,0,,1,INPP5D
insulin binding,GO:0043559,Alzheimer Disease,MESH:D000544,0,,3,IDE|IGF1R|INSR
insulin-like growth factor binding,GO:0005520,Alzheimer Disease,MESH:D000544,0,,2,IGF1R|IGF2R
insulin-like growth factor I binding,GO:0031994,Alzheimer Disease,MESH:D000544,0,,2,IGF1R|INSR
insulin-like growth factor II binding,GO:0031995,Alzheimer Disease,MESH:D000544,0,,2,IGF2R|INSR
insulin-like growth factor receptor activity,GO:0005010,Alzheimer Disease,MESH:D000544,0,,4,EPHA1|IGF1R|IGF2R|INSR
insulin-like growth factor receptor binding,GO:0005159,Alzheimer Disease,MESH:D000544,0,,4,IGF1|IGF2|INS|INSR
insulin receptor activity,GO:0005009,Alzheimer Disease,MESH:D000544,0,,3,EPHA1|IGF1R|INSR
insulin receptor binding,GO:0005158,Alzheimer Disease,MESH:D000544,0,,5,APP|IGF1|IGF1R|IGF2|INS
insulin receptor substrate binding,GO:0043560,Alzheimer Disease,MESH:D000544,0,,2,IGF1R|INSR
insulin-responsive glucose:proton symporter activity,GO:0005360,Alzheimer Disease,MESH:D000544,0,,1,SLC2A4
integrin binding,GO:0005178,Alzheimer Disease,MESH:D000544,0,,6,ADAM10|APP|GSK3B|IGF1|IGF2|IL1B
integrin binding,GO:0005178,ALZHEIMER DISEASE 18,OMIM:615590,0,,1,ADAM10
interleukin-1 binding,GO:0019966,Alzheimer Disease,MESH:D000544,0,,1,A2M
interleukin-1 receptor binding,GO:0005149,Alzheimer Disease,MESH:D000544,0,,1,IL1B
interleukin-8 binding,GO:0019959,Alzheimer Disease,MESH:D000544,0,,1,A2M
intracellular cAMP-activated cation channel activity,GO:0005222,Alzheimer Disease,MESH:D000544,1,Dronabinol,0,
ionotropic glutamate receptor binding,GO:0035255,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
iron chaperone activity,GO:0034986,Alzheimer Disease,MESH:D000544,0,,1,TF
iron ion binding,GO:0005506,Alzheimer Disease,MESH:D000544,1,Cadmium,2,CYP2D6|CYP46A1
isocitrate dehydrogenase (NAD+) activity,GO:0004449,Alzheimer Disease,MESH:D000544,2,Apigenin|Zinc,0,
isocitrate dehydrogenase (NADP+) activity,GO:0004450,Alzheimer Disease,MESH:D000544,2,Acrolein|Zinc,0,
isocitrate dehydrogenase [NAD(P)+] activity,GO:0004448,Alzheimer Disease,MESH:D000544,4,Cadmium|Copper|Copper Sulfate|Iron,0,
isomerase activity,GO:0016853,Alzheimer Disease,MESH:D000544,0,,1,TPI1
JUN kinase activity,GO:0004705,Alzheimer Disease,MESH:D000544,2,Apigenin|Cadmium,0,
kinase activator activity,GO:0019209,Alzheimer Disease,MESH:D000544,0,,1,TREM2
kinase activity,GO:0016301,Alzheimer Disease,MESH:D000544,0,,3,CALM1|GSK3B|PLAU
lactase activity,GO:0000016,Alzheimer Disease,MESH:D000544,1,Streptozocin,0,
lactate dehydrogenase activity,GO:0004457,Alzheimer Disease,MESH:D000544,27,"Air Pollutants|Aluminum Chloride|Apigenin|Berberine|Cadmium|Celecoxib|Copper Sulfate|Curcumin|Dichlorodiphenyl Dichloroethylene|Ellagic Acid|Fluorides|Folic Acid|Galactose|Glucose|Homocysteine|Hydrogen Peroxide|Nanotubes, Carbon|Nicotine|Ozone|Particulate Matter|Plant Extracts|Raloxifene Hydrochloride|Resveratrol|Sodium Fluoride|Streptozocin|Tadalafil|Zinc",0,
lactate dehydrogenase activity,GO:0004457,Alzheimer disease type 2,MESH:C536595,1,Manganese,0,
L-alanine:2-oxoglutarate aminotransferase activity,GO:0004021,Alzheimer Disease,MESH:D000544,1,Plant Extracts,0,
lamin binding,GO:0005521,Alzheimer Disease,MESH:D000544,0,,1,PRNP
laminin binding,GO:0043236,Alzheimer Disease,MESH:D000544,0,,1,ACHE
L-aspartate:2-oxoglutarate aminotransferase activity,GO:0004069,Alzheimer Disease,MESH:D000544,26,"2-butenal|Aluminum Chloride|Apigenin|Berberine|Cadmium|Cholesterol, Dietary|Colchicine|Copper Sulfate|Curcumin|Dronabinol|Fluorides|Folic Acid|Homocysteine|Hydrogen Peroxide|Iron|Melatonin|Nanotubes, Carbon|Nicotine|Ozone|Paroxetine|Plant Extracts|Resveratrol|Rosiglitazone|Sodium Fluoride|Streptozocin|Zinc",0,
LBD domain binding,GO:0050693,Alzheimer Disease,MESH:D000544,0,,1,PPARG
leptin receptor binding,GO:1990460,Alzheimer Disease,MESH:D000544,0,,1,LEP
ligand-gated monoatomic ion channel activity,GO:0015276,Alzheimer Disease,MESH:D000544,0,,1,CHRNB2
lipase activity,GO:0016298,Alzheimer Disease,MESH:D000544,4,"Berberine|Cholesterol, Dietary|Ozone|Plant Extracts",0,
lipase inhibitor activity,GO:0055102,Alzheimer Disease,MESH:D000544,0,,1,APOC1
lipid binding,GO:0008289,Alzheimer Disease,MESH:D000544,0,,6,APOE|BAX|BIN1|ESR1|PGRMC1|TREM2
lipid binding,GO:0008289,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
lipid binding,GO:0008289,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
lipid binding,GO:0008289,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
lipid transporter activity,GO:0005319,Alzheimer Disease,MESH:D000544,0,,2,ABCA7|APOE
lipid transporter activity,GO:0005319,Alzheimer Disease 9,MESH:C563834,0,,1,ABCA7
lipid transporter activity,GO:0005319,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
lipid transporter activity,GO:0005319,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
lipid transporter activity,GO:0005319,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
lipoic acid binding,GO:0031405,Alzheimer Disease,MESH:D000544,0,,1,INSR
lipopolysaccharide binding,GO:0001530,Alzheimer Disease,MESH:D000544,0,,2,F2|TREM2
lipoprotein particle binding,GO:0071813,Alzheimer Disease,MESH:D000544,0,,3,APOE|MAPT|TREM2
lipoprotein particle binding,GO:0071813,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
lipoprotein particle binding,GO:0071813,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
lipoprotein particle binding,GO:0071813,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
lipoprotein particle receptor binding,GO:0070325,Alzheimer Disease,MESH:D000544,0,,1,RELN
lipoteichoic acid binding,GO:0070891,Alzheimer Disease,MESH:D000544,0,,2,ATP5F1A|TREM2
L-lactate dehydrogenase activity,GO:0004459,Alzheimer Disease,MESH:D000544,1,"Metals, Heavy",0,
low-density lipoprotein particle binding,GO:0030169,Alzheimer Disease,MESH:D000544,0,,1,TREM2
low-density lipoprotein particle receptor binding,GO:0050750,Alzheimer Disease,MESH:D000544,0,,4,APOE|APP|CLU|PICALM
low-density lipoprotein particle receptor binding,GO:0050750,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
low-density lipoprotein particle receptor binding,GO:0050750,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
low-density lipoprotein particle receptor binding,GO:0050750,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
lyase activity,GO:0016829,Alzheimer Disease,MESH:D000544,0,,2,ENO1|TPI1
lysine-acetylated histone binding,GO:0070577,Alzheimer Disease,MESH:D000544,2,Dichlorodiphenyl Dichloroethylene|Nicotine,0,
lysine-acetylated histone binding,GO:0070577,Alzheimer disease type 2,MESH:C536595,1,Manganese,0,
lysophosphatidic acid binding,GO:0035727,Alzheimer Disease,MESH:D000544,0,,1,TPP1
macrophage colony-stimulating factor receptor activity,GO:0005011,Alzheimer Disease,MESH:D000544,0,,3,EPHA1|IGF1R|INSR
magnesium ion binding,GO:0000287,Alzheimer Disease,MESH:D000544,0,,1,ENO1
malate dehydrogenase activity,GO:0016615,Alzheimer Disease,MESH:D000544,4,Air Pollutants|Cadmium|Curcumin|Particulate Matter,0,
malic enzyme activity,GO:0004470,Alzheimer Disease,MESH:D000544,4,Copper|Copper Sulfate|Glucose|Zinc,0,
maltose alpha-glucosidase activity,GO:0032450,Alzheimer Disease,MESH:D000544,1,Streptozocin,0,
manganese ion binding,GO:0030145,Alzheimer Disease,MESH:D000544,0,,1,SOD2
mannose binding,GO:0005537,Alzheimer Disease,MESH:D000544,0,,1,IGF2R
MAP kinase activity,GO:0004707,Alzheimer Disease,MESH:D000544,2,Cadmium|Dronabinol,0,
metal chelating activity,GO:0046911,Alzheimer Disease,MESH:D000544,1,Hydrogen Peroxide,1,APOE
metal chelating activity,GO:0046911,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
metal chelating activity,GO:0046911,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
metal chelating activity,GO:0046911,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
metal ion binding,GO:0046872,Alzheimer Disease,MESH:D000544,0,,23,ACE|ADAM10|ADAMTS1|APP|CALM1|CYP2D6|CYP46A1|ENO1|ESR1|HMOX1|IDE|MPO|NOS3|PCDH11X|PGRMC1|PPARG|PRNP|RELN|SLC30A4|SOD2|TF|TPP1|VSNL1
metal ion binding,GO:0046872,ALZHEIMER DISEASE 18,OMIM:615590,0,,1,ADAM10
metallocarboxypeptidase activity,GO:0004181,Alzheimer Disease,MESH:D000544,0,,1,ACE
metallodipeptidase activity,GO:0070573,Alzheimer Disease,MESH:D000544,0,,2,ACE|ADAM10
metallodipeptidase activity,GO:0070573,ALZHEIMER DISEASE 18,OMIM:615590,0,,1,ADAM10
metalloendopeptidase activity,GO:0004222,Alzheimer Disease,MESH:D000544,0,,4,ACE|ADAM10|ADAMTS1|IDE
metalloendopeptidase activity,GO:0004222,ALZHEIMER DISEASE 18,OMIM:615590,0,,1,ADAM10
metalloendopeptidase activity involved in amyloid precursor protein catabolic process,GO:1902945,Alzheimer Disease,MESH:D000544,0,,1,ADAM10
metalloendopeptidase activity involved in amyloid precursor protein catabolic process,GO:1902945,ALZHEIMER DISEASE 18,OMIM:615590,0,,1,ADAM10
metallopeptidase activity,GO:0008237,Alzheimer Disease,MESH:D000544,0,,4,ACE|ADAM10|ADAMTS1|IDE
metallopeptidase activity,GO:0008237,ALZHEIMER DISEASE 18,OMIM:615590,0,,1,ADAM10
methylated histone binding,GO:0035064,Alzheimer Disease,MESH:D000544,3,Dichlorodiphenyl Dichloroethylene|Ginkgo biloba extract|Particulate Matter,0,
methylenetetrahydrofolate reductase (NAD(P)H) activity,GO:0004489,Alzheimer Disease,MESH:D000544,0,,1,MTHFR
methylenetetrahydrofolate reductase NADPH activity,GO:0106313,Alzheimer Disease,MESH:D000544,0,,1,MTHFR
methylglyoxal synthase activity,GO:0008929,Alzheimer Disease,MESH:D000544,0,,1,TPI1
methyltransferase activity,GO:0008168,Alzheimer Disease,MESH:D000544,1,Ozone,0,
MHC class I protein binding,GO:0042288,Alzheimer Disease,MESH:D000544,0,,2,ATP5F1A|PILRA
microtubule binding,GO:0008017,Alzheimer Disease,MESH:D000544,0,,2,MAPT|PRNP
microtubule lateral binding,GO:0099609,Alzheimer Disease,MESH:D000544,0,,1,MAPT
microtubule motor activity,GO:0003777,Alzheimer Disease,MESH:D000544,2,Glucose|Hydrogen Peroxide,0,
minor groove of adenine-thymine-rich DNA binding,GO:0003680,Alzheimer Disease,MESH:D000544,0,,1,MAPT
misfolded protein binding,GO:0051787,Alzheimer Disease,MESH:D000544,0,,1,CLU
mitochondrial promoter sequence-specific DNA binding,GO:0001018,Alzheimer Disease,MESH:D000544,0,,1,TFAM
mitochondrial transcription factor activity,GO:0034246,Alzheimer Disease,MESH:D000544,0,,1,TFAM
mitogen-activated protein kinase binding,GO:0051019,Alzheimer Disease,MESH:D000544,0,,1,ACE
mitogen-activated protein kinase kinase binding,GO:0031434,Alzheimer Disease,MESH:D000544,0,,1,ACE
modified amino acid binding,GO:0072341,Alzheimer Disease,MESH:D000544,0,,1,MTHFR
molecular adaptor activity,GO:0060090,Alzheimer Disease,MESH:D000544,0,,3,ADAM10|BCL2|PRNP
molecular adaptor activity,GO:0060090,ALZHEIMER DISEASE 18,OMIM:615590,0,,1,ADAM10
molecular condensate scaffold activity,GO:0140693,Alzheimer Disease,MESH:D000544,0,,1,PRNP
molecular_function,GO:0003674,Alzheimer Disease,MESH:D000544,0,,5,CCDC6|CD2AP|IQCK|MS4A4A|TSPAN14
molecular function activator activity,GO:0140677,Alzheimer Disease,MESH:D000544,0,,1,PRNP
monoamine oxidase activity,GO:0097621,Alzheimer Disease,MESH:D000544,5,Aluminum|Berberine|Cadmium|Ellagic Acid|Fluorides,1,MAOB
monoatomic cation channel activity,GO:0005261,Alzheimer Disease,MESH:D000544,0,,1,TOMM40
monoatomic cation transmembrane transporter activity,GO:0008324,Alzheimer Disease,MESH:D000544,0,,2,SLC30A4|SLC30A6
monoatomic ion channel activity,GO:0005216,Alzheimer Disease,MESH:D000544,0,,2,CHRNA7|CHRNB2
monodehydroascorbate reductase (NADH) activity,GO:0016656,Alzheimer Disease,MESH:D000544,1,cupric chloride,0,
monooxygenase activity,GO:0004497,Alzheimer Disease,MESH:D000544,0,,2,CYP2D6|CYP46A1
mRNA 3'-UTR binding,GO:0003730,Alzheimer Disease,MESH:D000544,0,,5,MIR100|MIR146A|MIR296|MIR505|MIR708
mRNA base-pairing translational repressor activity,GO:1903231,Alzheimer Disease,MESH:D000544,0,,5,MIR100|MIR146A|MIR296|MIR505|MIR708
mRNA binding,GO:0003729,Alzheimer Disease,MESH:D000544,0,,3,ARC|CLU|MIR124A-3
myosin phosphatase activity,GO:0017018,Alzheimer Disease,MESH:D000544,1,Glucose,0,
NAD binding,GO:0051287,Alzheimer Disease,MESH:D000544,0,,1,GAPDHS
NADH dehydrogenase activity,GO:0003954,Alzheimer Disease,MESH:D000544,1,Streptozocin,0,
NADH dehydrogenase (ubiquinone) activity,GO:0008137,Alzheimer Disease,MESH:D000544,27,2-butenal|Acrolein|Air Pollutants|Apigenin|Berberine|Cadmium|Cannabidiol|Copper Sulfate|Curcumin|Deferoxamine|Dronabinol|Ellagic Acid|Fluorides|Glucose|Haloperidol|Hydrogen Peroxide|Kainic Acid|Lithium|Minocycline|Nitrites|Ozone|Particulate Matter|Plant Extracts|Resveratrol|Rosiglitazone|Sodium Fluoride|Streptozocin,0,
NADP binding,GO:0050661,Alzheimer Disease,MESH:D000544,0,,3,GAPDHS|MTHFR|NOS3
NAD(P)H oxidase H2O2-forming activity,GO:0016174,Alzheimer Disease,MESH:D000544,8,Air Pollutants|Aluminum Chloride|Celecoxib|Glucose|Hydrogen Peroxide|Nicotine|Particulate Matter|Resveratrol,0,
NAD+-protein ADP-ribosyltransferase activity,GO:1990404,Alzheimer Disease,MESH:D000544,1,Hydrogen Peroxide,0,
nerve growth factor binding,GO:0048406,Alzheimer Disease,MESH:D000544,0,,1,A2M
nerve growth factor receptor binding,GO:0005163,Alzheimer Disease,MESH:D000544,0,,1,BDNF
neuropeptide hormone activity,GO:0005184,Alzheimer Disease,MESH:D000544,0,,3,CRH|NPY|PYY
neuropeptide Y receptor binding,GO:0031841,Alzheimer Disease,MESH:D000544,0,,2,NPY|PYY
neuropilin binding,GO:0038191,Alzheimer Disease,MESH:D000544,0,,1,VEGFA
neurotransmitter receptor activity,GO:0030594,Alzheimer Disease,MESH:D000544,0,,2,CHRNA7|CHRNB2
neurotransmitter receptor regulator activity,GO:0099602,Alzheimer Disease,MESH:D000544,0,,1,PTK2B
neurotrophin TRKB receptor binding,GO:0005169,Alzheimer Disease,MESH:D000544,0,,1,BDNF
NF-kappaB binding,GO:0051059,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
nitric-oxide synthase activity,GO:0004517,Alzheimer Disease,MESH:D000544,2,Cadmium|Resveratrol,1,NOS3
nitric-oxide synthase binding,GO:0050998,Alzheimer Disease,MESH:D000544,0,,2,CALM1|NOS3
nitric-oxide synthase regulator activity,GO:0030235,Alzheimer Disease,MESH:D000544,0,,2,CALM1|ESR1
NMDA glutamate receptor activity,GO:0004972,Alzheimer Disease,MESH:D000544,1,Glucose,0,
non-membrane spanning protein tyrosine kinase activity,GO:0004715,Alzheimer Disease,MESH:D000544,0,,1,PTK2B
nuclear estrogen receptor activity,GO:0030284,Alzheimer Disease,MESH:D000544,0,,1,ESR1
nuclear estrogen receptor binding,GO:0030331,Alzheimer Disease,MESH:D000544,0,,2,ESR1|PPARG
nuclear receptor activity,GO:0004879,Alzheimer Disease,MESH:D000544,0,,3,ESR1|INPP5D|PPARG
nuclear retinoid X receptor binding,GO:0046965,Alzheimer Disease,MESH:D000544,0,,1,PPARG
nuclear steroid receptor activity,GO:0003707,Alzheimer Disease,MESH:D000544,0,,1,ESR1
nucleic acid binding,GO:0003676,Alzheimer Disease,MESH:D000544,0,,5,ARC|IGF1|PPARG|TSPAN14|WWOX
nucleoside triphosphate diphosphatase activity,GO:0047429,Alzheimer Disease,MESH:D000544,1,Streptozocin,0,
nucleotide binding,GO:0000166,Alzheimer Disease,MESH:D000544,0,,3,ABCA7|AMFR|ATP7
nucleotide binding,GO:0000166,Alzheimer Disease 9,MESH:C563834,0,,1,ABCA7
nutrient reservoir activity,GO:0045735,Alzheimer Disease,MESH:D000544,2,Air Pollutants|Particulate Matter,0,
oxidoreductase activity,GO:0016491,Alzheimer Disease,MESH:D000544,0,,9,CYP2D6|DHCR24|GAPDHS|MAOB|MPO|MTHFR|NOS3|SOD2|WWOX
"oxidoreductase activity, acting on NAD(P)H",GO:0016651,Alzheimer Disease,MESH:D000544,1,Curcumin,0,
"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen",GO:0016712,Alzheimer Disease,MESH:D000544,0,,1,CYP2D6
"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",GO:0016620,Alzheimer Disease,MESH:D000544,0,,2,GAPDHS|SPRED2
"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor",GO:0016628,Alzheimer Disease,MESH:D000544,0,,1,DHCR24
"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",GO:0016616,Alzheimer Disease,MESH:D000544,0,,1,WWOX
oxoglutarate dehydrogenase (succinyl-transferring) activity,GO:0004591,Alzheimer Disease,MESH:D000544,1,Cadmium,0,
oxygen binding,GO:0019825,Alzheimer Disease,MESH:D000544,2,Curcumin|Resveratrol,1,SOD2
p53 binding,GO:0002039,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
palmitoyltransferase activity,GO:0016409,Alzheimer Disease,MESH:D000544,0,,1,APP
PDZ domain binding,GO:0030165,Alzheimer Disease,MESH:D000544,0,,1,PSEN1
PDZ domain binding,GO:0030165,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,PSEN1
peptidase activator activity,GO:0016504,Alzheimer Disease,MESH:D000544,0,,1,APP
peptidase activator activity involved in apoptotic process,GO:0016505,Alzheimer Disease,MESH:D000544,6,Deferoxamine|Glucose|Hydrogen Peroxide|Kainic Acid|Melatonin|Plant Extracts,0,
peptidase activity,GO:0008233,Alzheimer Disease,MESH:D000544,1,Particulate Matter,11,ACE|ADAMTS1|BACE1|CASP3|F2|IDE|NCSTN|PLAU|PSEN1|PSEN2|TPP1
peptidase activity,GO:0008233,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,PSEN1
peptidase activity,GO:0008233,Alzheimer disease type 4,MESH:C536596,0,,1,PSEN2
peptidase inhibitor activity,GO:0030414,Alzheimer Disease,MESH:D000544,0,,2,A2M|CST3
peptide antigen binding,GO:0042605,Alzheimer Disease,MESH:D000544,0,,3,DHCR24|HFE|HLA-DRB5
peptide binding,GO:0042277,Alzheimer Disease,MESH:D000544,0,,3,IDE|PPARG|TPP1
peptide hormone binding,GO:0017046,Alzheimer Disease,MESH:D000544,0,,1,IDE
peptide hormone receptor binding,GO:0051428,Alzheimer Disease,MESH:D000544,0,,1,LEP
peptidoglycan binding,GO:0042834,Alzheimer Disease,MESH:D000544,0,,1,TREM2
peptidyl-dipeptidase activity,GO:0008241,Alzheimer Disease,MESH:D000544,0,,1,ACE
peptidyl-prolyl cis-trans isomerase activity,GO:0003755,Alzheimer Disease,MESH:D000544,0,,1,APOE
peptidyl-prolyl cis-trans isomerase activity,GO:0003755,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
peptidyl-prolyl cis-trans isomerase activity,GO:0003755,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
peptidyl-prolyl cis-trans isomerase activity,GO:0003755,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
peroxidase activity,GO:0004601,Alzheimer Disease,MESH:D000544,1,Curcumin,1,MPO
phosphatase activity,GO:0016791,Alzheimer Disease,MESH:D000544,1,Cadmium,1,INPP5D
phosphatidylcholine binding,GO:0031210,Alzheimer Disease,MESH:D000544,0,,1,APOC1
phosphatidylcholine floppase activity,GO:0090554,Alzheimer Disease,MESH:D000544,0,,1,ABCA7
phosphatidylcholine floppase activity,GO:0090554,Alzheimer Disease 9,MESH:C563834,0,,1,ABCA7
phosphatidylcholine phospholipase C activity,GO:0034480,Alzheimer Disease,MESH:D000544,0,,1,PLCG2
phosphatidylcholine-sterol O-acyltransferase activator activity,GO:0060228,Alzheimer Disease,MESH:D000544,0,,2,APOC1|APOE
phosphatidylcholine-sterol O-acyltransferase activator activity,GO:0060228,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
phosphatidylcholine-sterol O-acyltransferase activator activity,GO:0060228,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
phosphatidylcholine-sterol O-acyltransferase activator activity,GO:0060228,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
phosphatidylethanolamine binding,GO:0008429,Alzheimer Disease,MESH:D000544,0,,1,TREM2
"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity",GO:0016314,Alzheimer Disease,MESH:D000544,0,,1,INPP5D
"phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity",GO:0034485,Alzheimer Disease,MESH:D000544,0,,1,INPP5D
phosphatidylinositol 3-kinase activity,GO:0035004,Alzheimer Disease,MESH:D000544,1,Sodium Fluoride,0,
phosphatidylinositol 3-kinase binding,GO:0043548,Alzheimer Disease,MESH:D000544,0,,3,CALM1|IGF1R|INSR
phosphatidylinositol 3-kinase regulatory subunit binding,GO:0036312,Alzheimer Disease,MESH:D000544,0,,2,CD2AP|ESR1
"phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity",GO:0004439,Alzheimer Disease,MESH:D000544,0,,1,INPP5D
"phosphatidylinositol-4,5-bisphosphate binding",GO:0005546,Alzheimer Disease,MESH:D000544,0,,1,PICALM
phosphatidylinositol binding,GO:0035091,Alzheimer Disease,MESH:D000544,0,,1,MAPT
phosphatidylinositol bisphosphate binding,GO:1902936,Alzheimer Disease,MESH:D000544,0,,1,MAPT
phosphatidylinositol phospholipase C activity,GO:0004435,Alzheimer Disease,MESH:D000544,0,,1,PLCG2
phosphatidylserine binding,GO:0001786,Alzheimer Disease,MESH:D000544,0,,1,TREM2
phosphatidylserine floppase activity,GO:0090556,Alzheimer Disease,MESH:D000544,1,Reactive Oxygen Species,1,ABCA7
phosphatidylserine floppase activity,GO:0090556,Alzheimer Disease 9,MESH:C563834,0,,1,ABCA7
phosphoenolpyruvate carboxykinase activity,GO:0004611,Alzheimer Disease,MESH:D000544,2,Plant Extracts|Streptozocin,0,
phosphofructokinase activity,GO:0008443,Alzheimer Disease,MESH:D000544,1,Acrolein,0,
phospholipase A2 activator activity,GO:0016005,Alzheimer Disease,MESH:D000544,0,,1,CASP3
phospholipase A2 activity,GO:0004623,Alzheimer Disease,MESH:D000544,2,Cadmium|Indomethacin,0,
phospholipase C activity,GO:0004629,Alzheimer Disease,MESH:D000544,0,,1,PLCG2
phospholipase D activity,GO:0004630,Alzheimer Disease,MESH:D000544,0,,1,HMOX1
phospholipase inhibitor activity,GO:0004859,Alzheimer Disease,MESH:D000544,0,,1,APOC1
phospholipid binding,GO:0005543,Alzheimer Disease,MESH:D000544,0,,3,APOE|BIN1|TREM2
phospholipid binding,GO:0005543,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
phospholipid binding,GO:0005543,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
phospholipid binding,GO:0005543,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
phospholipid transporter activity,GO:0005548,Alzheimer Disease,MESH:D000544,0,,1,ABCA7
phospholipid transporter activity,GO:0005548,Alzheimer Disease 9,MESH:C563834,0,,1,ABCA7
phosphoprotein binding,GO:0051219,Alzheimer Disease,MESH:D000544,0,,1,IGF2R
phosphopyruvate hydratase activity,GO:0004634,Alzheimer Disease,MESH:D000544,0,,1,ENO1
phosphoric diester hydrolase activity,GO:0008081,Alzheimer Disease,MESH:D000544,0,,1,PLCG2
phosphorylation-dependent protein binding,GO:0140031,Alzheimer Disease,MESH:D000544,0,,1,PLCG2
phosphotyrosine residue binding,GO:0001784,Alzheimer Disease,MESH:D000544,0,,2,NCK2|PLCG2
placental growth factor receptor activity,GO:0036332,Alzheimer Disease,MESH:D000544,0,,3,EPHA1|IGF1R|INSR
platelet-derived growth factor alpha-receptor activity,GO:0005018,Alzheimer Disease,MESH:D000544,0,,3,EPHA1|IGF1R|INSR
platelet-derived growth factor beta-receptor activity,GO:0005019,Alzheimer Disease,MESH:D000544,0,,3,EPHA1|IGF1R|INSR
platelet-derived growth factor receptor binding,GO:0005161,Alzheimer Disease,MESH:D000544,0,,1,VEGFA
porin activity,GO:0015288,Alzheimer Disease,MESH:D000544,0,,1,TOMM40
preprotein binding,GO:0070678,Alzheimer Disease,MESH:D000544,0,,1,TOMM40
primary amine oxidase activity,GO:0008131,Alzheimer Disease,MESH:D000544,0,,1,MAOB
promoter-specific chromatin binding,GO:1990841,Alzheimer Disease,MESH:D000544,0,,2,ESR1|PPARG
prostaglandin-endoperoxide synthase activity,GO:0004666,Alzheimer Disease,MESH:D000544,2,"Cholesterol, Dietary|Particulate Matter",0,
prostaglandin receptor activity,GO:0004955,Alzheimer Disease,MESH:D000544,0,,1,PPARG
protease binding,GO:0002020,Alzheimer Disease,MESH:D000544,0,,10,A2M|ATP5F1A|BCL2|BIN1|CASP3|CST3|GSK3B|INS|PRNP|TNF
protein binding,GO:0005515,Alzheimer Disease,MESH:D000544,0,,94,A2M|ABCA7|ABI3|ACE|ACHE|ADAM10|ADAMTS1|AMFR|APH1B|APOC1|APOE|APP|ARC|ATP5F1A|BACE1|BAX|BCHE|BCL2|BDNF|BIN1|CALM1|CASP3|CASS4|CCDC6|CD2AP|CD33|CHRNA7|CHRNB2|CLU|CR1|CRH|CST3|DHCR24|DPYSL2|EIF2S1|ENO1|EPHA1|ESR1|F2|GAPDHS|GSK3B|HFE|HLA-DRB5|HMOX1|IDE|IGF1|IGF1R|IGF2|IGF2R|IL1B|INPP5D|INS|INSR|IQCK|LEP|MAOB|MAPT|MPO|MS4A4A|MTHFR|NCK2|NCSTN|NECTIN2|NOS3|NPY|PCDH11X|PGRMC1|PICALM|PILRA|PLAU|PLCG2|PPARG|PRNP|PSEN1|PSEN2|PTK2B|PYY|RELN|SLC2A4|SLC30A4|SLC30A6|SOD2|SPRED2|TF|TFAM|TNF|TOMM40|TPI1|TPP1|TREM2|TSPAN14|VEGFA|VSNL1|WWOX
protein binding,GO:0005515,ALZHEIMER DISEASE 18,OMIM:615590,0,,1,ADAM10
protein binding,GO:0005515,Alzheimer Disease 9,MESH:C563834,0,,1,ABCA7
protein binding,GO:0005515,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,2,APOE|PSEN1
protein binding,GO:0005515,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
protein binding,GO:0005515,Alzheimer disease type 4,MESH:C536596,0,,2,APOE|PSEN2
protein carrier chaperone,GO:0140597,Alzheimer Disease,MESH:D000544,0,,1,CLU
protein-containing complex binding,GO:0044877,Alzheimer Disease,MESH:D000544,0,,19,APOE|BAX|BCL2|BIN1|CASP3|CD2AP|CHRNB2|CLU|ENO1|ESR1|IDE|IGF1R|INSR|MAPT|MTHFR|NCK2|PRNP|PTK2B|TREM2
protein-containing complex binding,GO:0044877,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
protein-containing complex binding,GO:0044877,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
protein-containing complex binding,GO:0044877,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
protein-cysteine S-palmitoyltransferase activity,GO:0019706,Alzheimer Disease,MESH:D000544,0,,1,APP
protein dimerization activity,GO:0046983,Alzheimer Disease,MESH:D000544,0,,1,APOE
protein dimerization activity,GO:0046983,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
protein dimerization activity,GO:0046983,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
protein dimerization activity,GO:0046983,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
protein domain specific binding,GO:0019904,Alzheimer Disease,MESH:D000544,0,,4,APP|CALM1|IL1B|INSR
protein-glutamine gamma-glutamyltransferase activity,GO:0003810,Alzheimer Disease,MESH:D000544,1,Cadmium,0,
protein heterodimerization activity,GO:0046982,Alzheimer Disease,MESH:D000544,0,,4,APP|BAX|BCL2|CLU
protein homodimerization activity,GO:0042803,Alzheimer Disease,MESH:D000544,0,,15,ACE|ACHE|ADAM10|APOE|APP|BAX|BCL2|CHRNA7|ENO1|HMOX1|IDE|NECTIN2|PGRMC1|TPI1|VEGFA
protein homodimerization activity,GO:0042803,ALZHEIMER DISEASE 18,OMIM:615590,0,,1,ADAM10
protein homodimerization activity,GO:0042803,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
protein homodimerization activity,GO:0042803,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
protein homodimerization activity,GO:0042803,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
protein kinase A catalytic subunit binding,GO:0034236,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
protein kinase activator activity,GO:0030295,Alzheimer Disease,MESH:D000544,0,,1,INSR
protein kinase activity,GO:0004672,Alzheimer Disease,MESH:D000544,0,,4,EPHA1|GSK3B|INSR|PTK2B
protein kinase binding,GO:0019901,Alzheimer Disease,MESH:D000544,0,,12,ADAM10|APP|CALM1|CHRNA7|DPYSL2|EPHA1|ESR1|GSK3B|INSR|MAPT|PLCG2|SPRED2
protein kinase binding,GO:0019901,ALZHEIMER DISEASE 18,OMIM:615590,0,,1,ADAM10
protein kinase C activity,GO:0004697,Alzheimer Disease,MESH:D000544,3,Dichlorodiphenyl Dichloroethylene|Glucose|Streptozocin,0,
protein-macromolecule adaptor activity,GO:0030674,Alzheimer Disease,MESH:D000544,0,,4,AMFR|APH1B|MAPT|NCSTN
protein phosphatase 2A binding,GO:0051721,Alzheimer Disease,MESH:D000544,0,,2,BCL2|MAPT
protein phosphatase activator activity,GO:0072542,Alzheimer Disease,MESH:D000544,0,,1,CALM1
protein phosphatase binding,GO:0019903,Alzheimer Disease,MESH:D000544,0,,4,BCL2|CD33|INSR|PPARG
protein serine kinase activity,GO:0106310,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
protein serine/threonine kinase activator activity,GO:0043539,Alzheimer Disease,MESH:D000544,0,,3,CALM1|IGF1|IGF2
protein serine/threonine kinase activity,GO:0004674,Alzheimer Disease,MESH:D000544,1,Streptozocin,1,GSK3B
protein serine/threonine kinase binding,GO:0120283,Alzheimer Disease,MESH:D000544,0,,3,APP|BACE1|GSK3B
protein serine/threonine kinase inhibitor activity,GO:0030291,Alzheimer Disease,MESH:D000544,0,,1,SPRED2
protein transmembrane transporter activity,GO:0008320,Alzheimer Disease,MESH:D000544,0,,1,TOMM40
protein transporter activity,GO:0140318,Alzheimer Disease,MESH:D000544,0,,1,IGF1R
protein tyrosine kinase activity,GO:0004713,Alzheimer Disease,MESH:D000544,0,,3,IGF1R|INSR|PTK2B
protein tyrosine kinase binding,GO:1990782,Alzheimer Disease,MESH:D000544,0,,3,CASS4|PLCG2|TREM2
protein tyrosine kinase collagen receptor activity,GO:0038062,Alzheimer Disease,MESH:D000544,0,,3,EPHA1|IGF1R|INSR
protein tyrosine phosphatase activator activity,GO:0008160,Alzheimer Disease,MESH:D000544,0,,1,CD33
protein tyrosine phosphatase activity,GO:0004725,Alzheimer Disease,MESH:D000544,1,Particulate Matter,0,
"proton-transporting ATPase activity, rotational mechanism",GO:0046961,Alzheimer Disease,MESH:D000544,5,Apigenin|Curcumin|Ellagic Acid|Resveratrol|Zinc,0,
"proton-transporting ATP synthase activity, rotational mechanism",GO:0046933,Alzheimer Disease,MESH:D000544,2,Air Pollutants|Particulate Matter,1,ATP5F1A
PTB domain binding,GO:0051425,Alzheimer Disease,MESH:D000544,0,,2,APP|INSR
P-type calcium transporter activity,GO:0005388,Alzheimer Disease,MESH:D000544,3,Apigenin|Cadmium|Curcumin,0,
P-type divalent copper transporter activity,GO:0043682,Alzheimer Disease,MESH:D000544,0,,1,ATP7
P-type magnesium transporter activity,GO:0015444,Alzheimer Disease,MESH:D000544,1,Cadmium,0,
P-type sodium:potassium-exchanging transporter activity,GO:0005391,Alzheimer Disease,MESH:D000544,13,Aluminum Chloride|Apigenin|Cadmium|Curcumin|Folic Acid|Glucose|Indomethacin|Kainic Acid|Reserpine|Resveratrol|Serotonin|Streptozocin|Zinc,0,
P-type sodium:potassium-exchanging transporter activity,GO:0005391,Alzheimer disease type 2,MESH:C536595,1,Manganese,0,
pyruvate kinase activity,GO:0004743,Alzheimer Disease,MESH:D000544,4,Air Pollutants|Particulate Matter|Streptozocin|Tadalafil,0,
quaternary ammonium group binding,GO:0050997,Alzheimer Disease,MESH:D000544,0,,1,CHRNB2
RAGE receptor binding,GO:0050786,Alzheimer Disease,MESH:D000544,0,,1,APP
receptor ligand activity,GO:0048018,Alzheimer Disease,MESH:D000544,0,,11,APOE|APP|CLU|F2|IGF1|IGF2|IL1B|NECTIN2|RELN|TNF|VEGFA
receptor ligand activity,GO:0048018,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
receptor ligand activity,GO:0048018,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
receptor ligand activity,GO:0048018,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
receptor tyrosine kinase binding,GO:0030971,Alzheimer Disease,MESH:D000544,0,,1,NCK2
retinoic acid binding,GO:0001972,Alzheimer Disease,MESH:D000544,0,,1,IGF2R
retromer complex binding,GO:1905394,Alzheimer Disease,MESH:D000544,0,,1,IGF2R
Rho-dependent protein serine/threonine kinase activity,GO:0072518,Alzheimer Disease,MESH:D000544,1,Dronabinol,1,GSK3B
ribosomal protein S6 kinase activity,GO:0004711,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
ribosome binding,GO:0043022,Alzheimer Disease,MESH:D000544,0,,2,CLU|EIF2S1
RNA binding,GO:0003723,Alzheimer Disease,MESH:D000544,0,,3,EIF2S1|ENO1|MAPT
RNA polymerase binding,GO:0070063,Alzheimer Disease,MESH:D000544,0,,1,BIN1
RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0000978,Alzheimer Disease,MESH:D000544,0,,3,APP|ESR1|PPARG
RNA polymerase II core promoter sequence-specific DNA binding,GO:0000979,Alzheimer Disease,MESH:D000544,0,,1,PPARG
RNA polymerase II-specific DNA-binding transcription factor binding,GO:0061629,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
RNA polymerase II transcription regulatory region sequence-specific DNA binding,GO:0000977,Alzheimer Disease,MESH:D000544,0,,3,ENO1|F2|PPARG
R-SMAD binding,GO:0070412,Alzheimer Disease,MESH:D000544,0,,1,PPARG
scaffold protein binding,GO:0097110,Alzheimer Disease,MESH:D000544,0,,6,CHRNA7|GSK3B|NCK2|NOS3|PLCG2|TREM2
semaphorin receptor activity,GO:0017154,Alzheimer Disease,MESH:D000544,0,,1,TREM2
semaphorin receptor binding,GO:0030215,Alzheimer Disease,MESH:D000544,0,,1,TREM2
sequence-specific DNA binding,GO:0043565,Alzheimer Disease,MESH:D000544,0,,5,BCL2|ESR1|MAPT|PPARG|TFAM
sequence-specific double-stranded DNA binding,GO:1990837,Alzheimer Disease,MESH:D000544,0,,1,ESR1
sequence-specific mRNA binding,GO:1990825,Alzheimer Disease,MESH:D000544,0,,1,MIR146A
serine hydrolase activity,GO:0017171,Alzheimer Disease,MESH:D000544,0,,1,ACHE
serine-type endopeptidase activity,GO:0004252,Alzheimer Disease,MESH:D000544,0,,3,F2|PLAU|TPP1
serine-type endopeptidase inhibitor activity,GO:0004867,Alzheimer Disease,MESH:D000544,0,,2,A2M|APP
serine-type peptidase activity,GO:0008236,Alzheimer Disease,MESH:D000544,0,,3,F2|RELN|TPP1
SH2 domain binding,GO:0042169,Alzheimer Disease,MESH:D000544,0,,1,ADAM10
SH2 domain binding,GO:0042169,ALZHEIMER DISEASE 18,OMIM:615590,0,,1,ADAM10
SH3 domain binding,GO:0017124,Alzheimer Disease,MESH:D000544,0,,7,ABI3|ADAM10|CCDC6|CD2AP|INPP5D|MAPT|PICALM
SH3 domain binding,GO:0017124,ALZHEIMER DISEASE 18,OMIM:615590,0,,1,ADAM10
sialic acid binding,GO:0033691,Alzheimer Disease,MESH:D000544,0,,1,CD33
signaling adaptor activity,GO:0035591,Alzheimer Disease,MESH:D000544,0,,3,ABI3|BIN1|NCK2
signaling receptor activator activity,GO:0030546,Alzheimer Disease,MESH:D000544,0,,1,APP
signaling receptor activity,GO:0038023,Alzheimer Disease,MESH:D000544,0,,5,AMFR|CD33|IGF2R|PRNP|TREM2
signaling receptor binding,GO:0005102,Alzheimer Disease,MESH:D000544,0,,11,A2M|ADAM10|APOE|APP|BDNF|CLU|CRH|F2|HFE|LEP|NPY
signaling receptor binding,GO:0005102,ALZHEIMER DISEASE 18,OMIM:615590,0,,1,ADAM10
signaling receptor binding,GO:0005102,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
signaling receptor binding,GO:0005102,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
signaling receptor binding,GO:0005102,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
signaling receptor complex adaptor activity,GO:0030159,Alzheimer Disease,MESH:D000544,0,,1,NCK2
single-stranded DNA binding,GO:0003697,Alzheimer Disease,MESH:D000544,0,,1,MAPT
small GTPase binding,GO:0031267,Alzheimer Disease,MESH:D000544,0,,1,PICALM
SNARE binding,GO:0000149,Alzheimer Disease,MESH:D000544,0,,1,PICALM
sodium channel activity,GO:0005272,Alzheimer Disease,MESH:D000544,2,Cadmium|Resveratrol,0,
starch synthase activity,GO:0009011,Alzheimer Disease,MESH:D000544,2,Nicotine|Streptozocin,0,
STAT family protein binding,GO:0097677,Alzheimer Disease,MESH:D000544,0,,1,PPARG
stem cell factor receptor activity,GO:0005020,Alzheimer Disease,MESH:D000544,0,,3,EPHA1|IGF1R|INSR
stem cell factor receptor binding,GO:0005173,Alzheimer Disease,MESH:D000544,0,,1,SPRED2
steroid binding,GO:0005496,Alzheimer Disease,MESH:D000544,0,,3,ESR1|IGF1|PGRMC1
steroid hormone binding,GO:1990239,Alzheimer Disease,MESH:D000544,0,,1,ESR1
steroid hydroxylase activity,GO:0008395,Alzheimer Disease,MESH:D000544,0,,1,CYP46A1
structural constituent of cytoskeleton,GO:0005200,Alzheimer Disease,MESH:D000544,0,,2,CCDC6|CD2AP
structural constituent of ribosome,GO:0003735,Alzheimer Disease,MESH:D000544,0,,1,CASS4
structural molecule activity,GO:0005198,Alzheimer Disease,MESH:D000544,0,,5,APOE|ARC|HMOX1|IGF1R|INSR
structural molecule activity,GO:0005198,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
structural molecule activity,GO:0005198,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
structural molecule activity,GO:0005198,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
succinate dehydrogenase activity,GO:0000104,Alzheimer Disease,MESH:D000544,9,Cadmium|Celecoxib|Curcumin|Hydrogen Peroxide|Niacin|Plant Extracts|Sodium Fluoride|Streptozocin|Zinc,0,
succinate dehydrogenase (ubiquinone) activity,GO:0008177,Alzheimer Disease,MESH:D000544,14,2-butenal|Berberine|Cadmium|Cannabidiol|Copper Sulfate|Curcumin|Deferoxamine|Dronabinol|Ellagic Acid|Glucose|Lithium|Melatonin|Nitrites|Streptozocin,0,
sucrose alpha-glucosidase activity,GO:0004575,Alzheimer Disease,MESH:D000544,3,Folic Acid|Streptozocin|Vitamin B 12,0,
sulfate binding,GO:0043199,Alzheimer Disease,MESH:D000544,0,,1,ACE
sulfatide binding,GO:0120146,Alzheimer Disease,MESH:D000544,0,,2,TPP1|TREM2
sulfotransferase activity,GO:0008146,Alzheimer Disease,MESH:D000544,1,Plant Extracts,0,
superoxide dismutase activity,GO:0004784,Alzheimer Disease,MESH:D000544,53,"2-butenal|5-Methoxypsoralen|6,7-dihydroxyflavone|Acrolein|Air Pollutants|Aluminum|Aluminum Chloride|Apigenin|Berberine|Cadmium|Cannabidiol|Celecoxib|Cholesterol, Dietary|Colchicine|Copper|Copper Sulfate|cupric chloride|Curcumin|Deferoxamine|Donepezil|Dronabinol|Ellagic Acid|Fluorides|Folic Acid|Galactose|Ginkgo biloba extract|Glucose|Homocysteine|Hydrogen Peroxide|Ibuprofen|icariin|Indomethacin|Iron|Melatonin|Nanotubes, Carbon|Niacin|Nicotine|Ozone|Paroxetine|Particulate Matter|Plant Extracts|Plant Preparations|puag-haad|Resveratrol|Rivastigmine|Rosiglitazone|Scopolamine|Sodium Fluoride|Streptozocin|Tacrine|Trichlorfon|Vitamin B 12|Zinc",1,SOD2
superoxide dismutase activity,GO:0004784,Alzheimer disease type 2,MESH:C536595,1,Manganese,0,
superoxide-generating NAD(P)H oxidase activity,GO:0016175,Alzheimer Disease,MESH:D000544,0,,1,NOS3
superoxide-generating NADPH oxidase activity,GO:0106292,Alzheimer Disease,MESH:D000544,2,Curcumin|Glucose,0,
tau protein binding,GO:0048156,Alzheimer Disease,MESH:D000544,0,,5,APOE|BIN1|CLU|GSK3B|PICALM
tau protein binding,GO:0048156,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
tau protein binding,GO:0048156,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
tau protein binding,GO:0048156,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
tau-protein kinase activity,GO:0050321,Alzheimer Disease,MESH:D000544,0,,1,GSK3B
TBP-class protein binding,GO:0017025,Alzheimer Disease,MESH:D000544,0,,1,ESR1
telomerase activity,GO:0003720,Alzheimer Disease,MESH:D000544,2,Air Pollutants|Particulate Matter,0,
testosterone 16-beta-hydroxylase activity,GO:0062184,Alzheimer Disease,MESH:D000544,0,,1,CYP46A1
testosterone 6-beta-hydroxylase activity,GO:0050649,Alzheimer Disease,MESH:D000544,0,,1,CYP46A1
tetrahydrobiopterin binding,GO:0034617,Alzheimer Disease,MESH:D000544,0,,1,NOS3
TFIIB-class transcription factor binding,GO:0001093,Alzheimer Disease,MESH:D000544,0,,1,ESR1
thioredoxin-disulfide reductase activity,GO:0004791,Alzheimer Disease,MESH:D000544,5,Cadmium|cupric chloride|Curcumin|Iron|Streptozocin,0,
thrombospondin receptor activity,GO:0070053,Alzheimer Disease,MESH:D000544,0,,1,F2
titin binding,GO:0031432,Alzheimer Disease,MESH:D000544,0,,1,CALM1
toxic substance binding,GO:0015643,Alzheimer Disease,MESH:D000544,0,,1,CHRNA7
transaminase activity,GO:0008483,Alzheimer Disease,MESH:D000544,2,"Metals, Heavy|Plant Extracts",0,
transcription cis-regulatory region binding,GO:0000976,Alzheimer Disease,MESH:D000544,0,,3,PPARG|TFAM|TNF
transcription coactivator activity,GO:0003713,Alzheimer Disease,MESH:D000544,0,,1,WWOX
transcription coactivator binding,GO:0001223,Alzheimer Disease,MESH:D000544,0,,3,ESR1|PPARG|TFAM
transcription coregulator binding,GO:0001221,Alzheimer Disease,MESH:D000544,0,,2,ESR1|PPARG
transcription corepressor activity,GO:0003714,Alzheimer Disease,MESH:D000544,0,,2,BIN1|ENO1
transcription corepressor binding,GO:0001222,Alzheimer Disease,MESH:D000544,0,,2,ENO1|ESR1
transcription factor binding,GO:0008134,Alzheimer Disease,MESH:D000544,0,,3,BCL2|BIN1|ESR1
transferrin receptor binding,GO:1990459,Alzheimer Disease,MESH:D000544,0,,2,HFE|TF
transition metal ion binding,GO:0046914,Alzheimer Disease,MESH:D000544,0,,2,APP|NCSTN
transketolase activity,GO:0004802,Alzheimer Disease,MESH:D000544,1,Glucose,0,
translation initiation factor activity,GO:0003743,Alzheimer Disease,MESH:D000544,0,,1,EIF2S1
transmembrane-ephrin receptor activity,GO:0005005,Alzheimer Disease,MESH:D000544,0,,3,EPHA1|IGF1R|INSR
transmembrane receptor protein tyrosine kinase activator activity,GO:0030297,Alzheimer Disease,MESH:D000544,0,,3,IGF1|IGF2|VEGFA
transmembrane receptor protein tyrosine kinase activity,GO:0004714,Alzheimer Disease,MESH:D000544,0,,3,IGF1R|INSR|PTK2B
transmembrane signaling receptor activity,GO:0004888,Alzheimer Disease,MESH:D000544,0,,3,CHRNA7|CHRNB2|TREM2
transmembrane transporter activity,GO:0022857,Alzheimer Disease,MESH:D000544,0,,2,CLU|SLC2A4
transmembrane transporter binding,GO:0044325,Alzheimer Disease,MESH:D000544,0,,3,CALM1|PRNP|TF
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential,GO:1904315,Alzheimer Disease,MESH:D000544,0,,2,CHRNA7|CHRNB2
trehalase activity,GO:0015927,Alzheimer Disease,MESH:D000544,1,Ozone,0,
triose-phosphate isomerase activity,GO:0004807,Alzheimer Disease,MESH:D000544,0,,1,TPI1
tripeptidyl-peptidase activity,GO:0008240,Alzheimer Disease,MESH:D000544,0,,2,ACE|TPP1
tRNA-intron endonuclease activity,GO:0000213,Alzheimer Disease,MESH:D000544,0,,1,PPARG
"tryptophan 2,3-dioxygenase activity",GO:0004833,Alzheimer Disease,MESH:D000544,1,Cadmium,0,
tubulin binding,GO:0015631,Alzheimer Disease,MESH:D000544,0,,1,PRNP
tumor necrosis factor binding,GO:0043120,Alzheimer Disease,MESH:D000544,0,,1,A2M
tumor necrosis factor receptor binding,GO:0005164,Alzheimer Disease,MESH:D000544,0,,1,TNF
type 1 metabotropic glutamate receptor binding,GO:0031798,Alzheimer Disease,MESH:D000544,0,,1,ESR1
type 2 neuropeptide Y receptor binding,GO:0031843,Alzheimer Disease,MESH:D000544,0,,1,NPY
type 3 metabotropic glutamate receptor binding,GO:0031800,Alzheimer Disease,MESH:D000544,0,,1,CALM1
type 5 metabotropic glutamate receptor binding,GO:0031802,Alzheimer Disease,MESH:D000544,0,,1,PRNP
ubiquinol-cytochrome-c reductase activity,GO:0008121,Alzheimer Disease,MESH:D000544,7,2-butenal|Cadmium|Curcumin|Deferoxamine|Ellagic Acid|Haloperidol|Nitrites,0,
ubiquitin binding,GO:0043130,Alzheimer Disease,MESH:D000544,0,,1,AMFR
ubiquitin protein ligase activity,GO:0061630,Alzheimer Disease,MESH:D000544,0,,2,AMFR|INS
ubiquitin protein ligase binding,GO:0031625,Alzheimer Disease,MESH:D000544,0,,5,BCL2|CLU|GSK3B|PTK2B|TPI1
ubiquitin-protein transferase activity,GO:0004842,Alzheimer Disease,MESH:D000544,0,,1,AMFR
ubiquitin-specific protease binding,GO:1990381,Alzheimer Disease,MESH:D000544,0,,1,AMFR
ubiquitin-ubiquitin ligase activity,GO:0034450,Alzheimer Disease,MESH:D000544,0,,1,AMFR
unfolded protein binding,GO:0051082,Alzheimer Disease,MESH:D000544,0,,1,CLU
vascular endothelial growth factor receptor 1 binding,GO:0043183,Alzheimer Disease,MESH:D000544,0,,1,VEGFA
vascular endothelial growth factor receptor 2 binding,GO:0043184,Alzheimer Disease,MESH:D000544,0,,1,VEGFA
vascular endothelial growth factor receptor activity,GO:0005021,Alzheimer Disease,MESH:D000544,0,,3,EPHA1|IGF1R|INSR
vascular endothelial growth factor receptor binding,GO:0005172,Alzheimer Disease,MESH:D000544,0,,2,CD2AP|VEGFA
very-low-density lipoprotein particle binding,GO:0034189,Alzheimer Disease,MESH:D000544,0,,1,TREM2
very-low-density lipoprotein particle receptor binding,GO:0070326,Alzheimer Disease,MESH:D000544,0,,2,APOE|RELN
very-low-density lipoprotein particle receptor binding,GO:0070326,"Alzheimer Disease, Familial, 3, with Spastic Paraparesis and Apraxia",MESH:C564330,0,,1,APOE
very-low-density lipoprotein particle receptor binding,GO:0070326,Alzheimer disease type 2,MESH:C536595,0,,1,APOE
very-low-density lipoprotein particle receptor binding,GO:0070326,Alzheimer disease type 4,MESH:C536596,0,,1,APOE
virus receptor activity,GO:0001618,Alzheimer Disease,MESH:D000544,0,,3,CR1|IDE|NECTIN2
voltage-gated calcium channel activity,GO:0005245,Alzheimer Disease,MESH:D000544,1,Glucose,0,
voltage-gated potassium channel activity,GO:0005249,Alzheimer Disease,MESH:D000544,1,Glucose,0,
WW domain binding,GO:0050699,Alzheimer Disease,MESH:D000544,0,,1,PPARG
xanthine oxidase activity,GO:0004855,Alzheimer Disease,MESH:D000544,2,Colchicine|Zinc,0,
zinc ion binding,GO:0008270,Alzheimer Disease,MESH:D000544,0,,8,ACE|ADAMTS1|AMFR|ARC|CLU|ESR1|IDE|PPARG
zinc ion transmembrane transporter activity,GO:0005385,Alzheimer Disease,MESH:D000544,0,,2,SLC30A4|SLC30A6
